key: cord-0889153-vc7tirfk
authors: Görgülü, Esra; Gu, Wenyi; Trebicka, Jonel; Mücke, Victoria Therese; Muecke, Marcus Maximilian; Friedrich-Rust, Mireen; Bojunga, Joerg; Zeuzem, Stefan; Finkelmeier, Fabian; Peiffer, Kai-Henrik
title: Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
date: 2021-06-17
journal: Gut
DOI: 10.1136/gutjnl-2021-325278
sha: d2711843b2fae17983dc6998e8344bb683353d1f
doc_id: 889153
cord_uid: vc7tirfk

nan

consensus on the definition of metabolic dysfunction for lean subjects. Francque and Wong 1 have also pointed out the misconception on the term 'lean', which generally indicates metabolically healthy condition. Therefore, we think that the presence of diabetes in these lean patients would be a good indicator of not only the presence of metabolic dysfunction but also the presence of hepatic fibrosis.

In summary, lean patients with NAFLD who have a lower number of metabolic risks showed a non-negligible prevalence of diabetes similar to that in non-lean patients with NAFLD. The presence of diabetes is the most specific predictive (but not necessarily causative) factor for hepatic fibrosis in lean patients with NAFLD.

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?

We have read with interest the study recently published by Bajaj and colleagues. 1 The authors convincingly demonstrate that underlying cirrhosis should be considered a high-risk comorbid condition among patients with COVID-19. However, increasing evidence demonstrates that patients not infected with SARS-CoV-2 are also highly affected by pandemic-related circumstances. While the COVID-19 pandemic led to a significant drop in medical emergencies with low priority presenting to emergency departments, 2 presentations of medical emergencies requiring urgent treatment appeared to be significantly delayed. For example, De Rosa et al 3 observed a reduction of nearly 50% in admissions for acute myocardial infarctions, but the case fatality rate and associated complications were substantially increased. In addition, several studies report an increase of psychological symptoms, such as anxiety, fear and stress, during the pandemic, which correlated significantly to a general increase in alcohol consumption. [4] [5] [6] Another study could show that alcohol consumption of heavy drinkers significantly increased. 7 Alcohol consumption is the main trigger of acute-on-chronic liver failure (ACLF), 8 which is a frequent syndrome in patients with underlying liver cirrhosis and is characterised by acute decompensation of cirrhosis, organ failure(s) and high short-term mortality. 9 We retrospectively analysed the prevalence and outcome of patients with ACLF precipitated by severe alcoholic hepatitis in a non-COVID-19 intensive care unit (ICU) of the University Liver Center in Frankfurt am Main (Hesse, Germany) during the SARS-CoV-2 pandemic in 2020 in comparison with equivalent time periods between 2017 and 2019. All patients admitted to the ICU were screened for ACLF, according to the European Association for the Study of the Liver -Chronic Liver Failure (EASL-CLIF) criteria, 10 via patient charts. Diagnosis of liver cirrhosis was based on clinical data, laboratory results, sonography and/or other imaging, liver biopsies and endoscopy. Patients with ACLF were categorised into two groups: (1) precipitated by severe alcoholic hepatitis and (2) precipitated by other causes. Severe alcoholic hepatitis was diagnosed as recently described. 8 Overall, 3649 admissions to ICU were screened during 2017-2020. Of these, 820 were admitted for a gastroenterological or hepatological disease and 237 patients presented with ACLF. In our analysis, a moderate increase in all ACLF cases was observed in 2020 in comparison with 2017-2019 (15.9% of all ICU cases in 2020 vs 12.2%-13% in 2017-2019, respectively). The majority of patients suffered from ACLF grade 2 and 3, and the median Model for End-Stage Liver Disease (MELD) score was 25 (table 1) . Importantly, in 2020, 57% of ACLF cases were precipitated by alcoholic hepatitis vs 24%-27% in 2017-2019, an increase of 111%-137% ( figure 1A ). This increase was even more pronounced over time during the pandemic and inversely correlated with reduced social activity due to pandemic-related government regulations (figure 1B). The group of patients with ACLF precipitated by severe alcoholic hepatitis included a higher percentage of ACLF grade 3 patients (53.7% vs 36.1%, respectively) and a slightly higher MELD score (27 In summary, in our liver centre, the rate of ACLF precipitated by acute severe alcoholic hepatitis markedly increased during the COVID-19 pandemic, which was associated with a high mortality. The apparent relationship with pandemicrelated circumstances advocates for more support for this vulnerable patient collective.

It is with great interest that we read the report of Yoshida et al 1 on the effect of secondgeneration narrow band imaging compared to white light imaging on detecting early gastric cancer in high-risk patients. The trial was expertly designed with a large patient population and, although superiority of narrow band imaging could not be proven, has important implications for further research on this topic. However, a significant issue concerning the analyses attracted our interest and we would like to comment on it.

The primary outcome, the difference in proportion of patients in whom early gastric cancer was diagnosed, failed to reach statistical significance (p=0.412). This difference in proportions was tested for significance using Fisher's exact test. This might not have been the proper method for analysis, as patients in the study were randomised using minimisation with a random component, stratified by institution, age and indication of endoscopy.

Imbalance of risk factors between treatment and control arms can occur by chance under normal randomisation, possibly leading to confounded treatment estimates. Stratification and minimisation are useful methods to ensure balance of risk factors between treatment arms. [2] [3] [4] These methods can be beneficial in small and large trials, but for trials larger than 1000 patients little effect of minimisation on imbalance was found as compared with simple randomisation. 4 One of the assumptions of Fisher's exact test is that samples are random and independent, which is not the case in this study. The problem that occurs with stratified or minimised randomisation is clustering between treatment groups which introduces positive correlation between observations. The correlation between observations violates the independence assumption and will lead to standard errors (SE) that are biased upwards because tests for independent samples do not account for this correlation and will overestimate the variance of the treatment effect.

As a SE that is biased upwards leads to inflated p values, not accounting for these balancing variables in the analysis may lead to wrongfully not rejecting the null hypothesis. This effect can be considerable, as a reanalysis of a large trial showed twofold to fourfold increases in p values and a simulation study showed reductions in power of up to 30 percentage points. 5 6 Thus, studies using either of the balancing methods should adjust their analysis for the balancing variables used in the randomisation procedure. 5 Considering the report of Yoshida et al, this could mean that they may have erroneously concluded that second-generation narrow band imaging was not superior to white light imaging. We cannot determine the precise effect adjustment would have had in the study by Yoshida et al as a reanalysis requires the individual patient data. While adjustment is possible using Fisher's exact test, 7 8 we suggest performing logistic regression analysis as this allows adjustment for multiple minimisation variables, does not rely on inefficient stratification, 8 and can be used to determine the confidence interval around the treatment effect estimate.

Unadjusted analyses in balanced randomised trials seem to be a recurring phenomenon. In 2012, a systematic review showed that only 26% of trials published in leading journals that used a balancing method correctly adjusted for all balancing factors. 6 But even in more recent trials analyses are often not adjusted for balancing factors, as shown by the study of Yoshida et al, but also by other trials in the leading journals of gastroenterology and hepatology. 1 9 10 When used correctly minimisation and stratification are powerful tools for balancing randomised trials and improving the validity of studies. However, this has important consequences for data analysis. As such, we urge trialists to include the balancing variables as adjustment factors in their statistical analyses.

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort

Medical emergencies during the COVID-19 pandemic

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown

Depression, anxiety and stress during the COVID-19 pandemic: results from a new Zealand cohort study on mental well-being

Mental health during the first weeks of the COVID-19 pandemic in the United States

Changes in alcohol consumption during the COVID-19 Pandemic-Small change in total consumption, but increase in proportion of heavy drinkers

Predict identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis

Acute-On-Chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis

Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Provenance and peer review Not commissioned; internally peer reviewed.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http:// creativecommons.org/licenses/by-nc/4.0/.